Leiurus quinquestriatus

Leiurus quinquestriatus is native to desert regions of North Africa and the Middle East, including Egypt, Sudan, Israel, Jordan, and parts of the Arabian Peninsula. It inhabits arid and semi-arid environments where it shelters under rocks, in crevices, or in burrows during the heat of the day.

L. quinquestriatus venom contains a powerful mix of neurotoxins, including chlorotoxin, agitoxin, and scyllatoxin, which target ion channels in nerve cells. While its venom is among the most potent of any scorpion species, deaths are relatively rare in adults but pose a serious risk to children, particularly in rural areas with limited access to antivenom.

Leiurus hebraeus was historically classified as a subspecies of L. quinquestriatus (designated L. q. hebraeus) before being elevated to full species status based on genetic and morphological distinctions. Both are commonly called 'deathstalker' scorpions and are found in overlapping regions of the Middle East, but they differ in subtle anatomical features and exact geographic distribution.

A peptide called chlorotoxin, isolated from deathstalker venom, has been developed into an experimental compound known as BLZ-100 (Tumor Paint) that binds selectively to cancer cells. This fluorescently tagged molecule has been used in clinical trials to help surgeons distinguish brain tumor tissue from healthy tissue during operations, improving the precision of tumor removal.